Watch Closely (two)pentobarbital will lower the extent or outcome of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Powerful CYP3A4 inducers may perhaps lessen suvorexant efficacy; if greater suvorexant dose needed, never exceed twenty mg/working day pento